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Abstract
Background: Art psychotherapy has greater potential for use with adults with mild to moderate learning disabilities
as it places less of a burden on verbal interaction to achieve positive therapeutic, psychological, and behavioural goals.
The feasibility study objectives include testing procedures, outcomes, validated tools, recruitment and attrition rates,
acceptability, and treatment fidelity for manualised interpersonal art psychotherapy.
Methods: Adult males and females with mild to moderate learning disabilities will be recruited from four NHS
secure hospitals. Twenty patients will be recruited and randomly assigned to one of two treatment groups:
fifteen 1-h individual sessions of manualised interpersonal art psychotherapy, or a treatment as usual waiting list
control group. The Modified Overt Aggression Scale will be administered to both treatment arms. Four patients
will be recruited to a single-case design component of the study exploring the acceptability of an attentional
condition.
Discussion: This multi-site study will assist in future trial planning and inform feasibility including, procedures,
treatment acceptability, therapist adherence, and estimation of samples size for a definitive RCT.
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Background
Art therapies, such as art psychotherapy, are currently
used in a range of NHS healthcare settings. They are in-
cluded in the UK National Institute for Health and Care
Excellence (NICE) adult and children and young people’s
guidelines for psychosis and schizophrenia and the guide-
lines for the treatment of depression in children and
young people [1–3]. Although art therapy is included in
NICE guidelines for psychosis and schizophrenia in adults,
a Cochrane review of art therapy [4] (two trials, n = 137)
concluded that the evidence of benefits and harms was
inconclusive.
A systematic narrative review of 15 trials [5] of group
art therapy reported lower levels of anxiety and depres-
sion, including a study of incarcerated men. The art ther-
apy trails reviewed were targeted at symptoms of
depression, anxiety, low mood, trauma, distress, reduced
QoL, low coping skills, and self-esteem [5]. However, the
studies were generally considered to be of low quality and
the need for future high-quality research in this area was
identified [5, 6]. A systematic review of art therapy studies
for traumatised adults found 6 clinical evaluations
(n = 223) but just one RCT including art therapy plus cog-
nitive behaviour therapy for victims of sexual assault and
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victims with post-traumatic stress disorder (PTSD (n = 8))
[7]. A realist review of art therapy for depression included
16 papers and identified 8 therapeutic factors that ex-
plained how art therapy works, including self-expression,
communication, understanding, and creativity [8].
A review of art therapy literature for people with learn-
ing or intellectual disabilities [9] found one RCT. Art fa-
cilitation with adults (n = 19) showed a difference
between language comprehension and social interaction
for the treatment group against the control group with an
analysis of covariance of post-test with pre-test scores as
covariates (p < .10) [10].
For people with learning disabilities, art psychotherapy
uses art media as its primary mode of communication
and having artistic skill and experience in art is not a
prerequisite. This can offer the opportunity for expres-
sion and communication in the context of a psycho-
logical therapy to people who find it hard to express
their thoughts and feelings verbally [9]. Through focus-
ing communication around visual material there is
greater potential for people with a learning disability,
limited English proficiency (LEP), and/or a mental health
difficulties, to develop understanding about themselves/
their health or behaviour/and what they can do to
enhance their well-being [11].
In offender populations a meta-synthesis review of the
role of art therapies in therapeutic goals identified associa-
tions with improvements in emotional literacy, quality of
life, and lower levels of arousal linked with feelings of
anger [12]. Examples of ‘proof of concept’ work in adult
offenders with learning disabilities have indicated positive
outcomes from art psychotherapy in single-case designs.
Reported improvements included reduced levels of ag-
gression after receiving up to twenty individual sessions of
treatment [13–15]. This preliminary work has led to the
development of a working manual for interpersonal art
psychotherapy that is being considered in this study.
Development of health technology and therapeutic in-
terventions that support a reduction in aggressive behav-
iour in adults with learning disabilities has potential for
clinical benefits for patients in England. Data collected
as part of a national learning disability census identified
a population of 3230 adults with learning disabilities be-
ing treated in hospital with a total of 1780 patients
(55%) having one or more recorded incident of self-
harm, accidents, physical assault, restraint, or seclusion
(either ‘present’ or ‘severe’ enough risk to require hos-
pital treatment). Within this group of patients, 5460 sep-
arate types of risk were recorded for either violence,
self-injury, or damage to property [16]. An international
literature review of inpatient violence and aggression
[17] reported that patients treated in forensic settings
are likely to be more violent than those in other settings
such as psychiatric units.
Future art therapy trials could mitigate potential per-
formance bias through being allocated to the active
treatment group and assess the relative efficacy of art
therapy using an attention art-based placebo control to
ensure that groups are treated equally [5]. In an attempt
to explore a possible comparator for a future trial, the
acceptability of an attentional control condition will be
tested using a single-case design [18] in parallel to the
randomised waiting list control study.
In an attentional condition the level of time and atten-
tion given to the participant should match that of the
treatment (structural equivalence of dose) and have a ra-
tionale for therapeutic benefit [19]. Relaxation therapy
to treat symptoms of anxiety is identified as specific psy-
chological intervention that can be considered with
adults with learning disability and mental health prob-
lems [20].The attentional condition being tested is mind-
ful colouring-in for relaxation. Adult art therapy,
mindful, and relaxation colouring-in books are now
widely available to purchase as a self-help resource.
Methods/design
Study aims and objectives
The aim of the study is to establish the feasibility of con-
ducting a definitive RCT of interpersonal art psychother-
apy, with a primary focus on implementation and
acceptability. The feasibility study will be carried out in
four NHS secure hospital sites in England with treat-
ment being provided by trained art psychotherapists
who are registered with the UK Health and Care Profes-
sions Council (HCPC).
The study objectives for the assessment of feasibility
are:
1. Recruitment and consent, such as patients
willingness to be randomised and clinicians
willingness to recruit their patients into the study.
2. Identifying issues related to seeking informed
consent and risks of coercion, including potential
for patients to participate in the study believing
it will positively or negatively influence their
inpatient treatment or detention under the mental
health act.
3. Procedures and materials, including suitability of
study information, suitability of outcome measures,
appraising burden of outcome measures and
validated tools and suitability of outcome data
collection procedures for maintaining data integrity
from multiple study sites.
4. Describing routine care and treatment as usual,
identifying characteristics of treatment as usual
across multiple sites, levels of high and medium/
low security, and individualised patient care pathways.
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5. Attrition and acceptability, including rates of
attendance for treatment and the acceptability
of a novel attentional condition, reasons for non-
attendance and/or drop-out, and lack of retention
for data collection at the follow-up points.
6. Identifying risks of contamination, such as patients
on the waiting list receiving active components of
the treatment during routine care and/or in the
attentional condition.
7. Treatment fidelity, identifying therapist adherence
with the required activity in the treatment manual
and piloting treatment fidelity checklist and procedures.
Design
Waiting list control
This multi-centre feasibility study will utilise a parallel-
group, participant-randomised design, with participants
being allocated to either manualised interpersonal art
psychotherapy and treatment as usual, or treatment as
usual only while being placed on a waiting list for inter-
personal art psychotherapy.
Single-case design
Four participants will be separately recruited to take part
in single-case multiple-intervention ‘ABACA’ design
studies [18] where measures are administered across ‘A’
= baseline (pre-therapy), ‘B’ = first treatment (mindful
colouring-in attentional condition), ‘A’ = baseline (wash
out period), ‘C’ = second treatment (interpersonal art
psychotherapy), ‘A’ = baseline (post-therapy).
Client interviews
A brief post-therapy semi-structured interview will be
carried out with participants. Questioning will explore
helpful and unhelpful aspects of therapy and the partici-
pant’s experience of taking part in the study.
Treatment fidelity and contamination
Audio recordings from all therapy sessions will be col-
lected. A random sample of 25% of recordings will be
blind rated using a therapy checklist by a researcher in-
dependent of all other aspects of the study. This assess-
ment will test treatment differentiation (did the
providers only deliver the target treatment and not other
treatments), treatment competency (did providers main-
tain the skill set learned in training), and treatment ad-
herence (delivery of the treatment components as
intended) [21]. The same procedure will be repeated for
audio recordings of the attentional condition to check
for presence or absence of components that could con-
stitute contamination from the manualised treatment.
Intervention
Interpersonal art psychotherapy
Interpersonal art psychotherapy has been developed and
manualised from practice-based evaluations [13–15]. Di-
rections for the therapist, in terms of style, approach, and
techniques, are given in detail in the manual. The inter-
personal component of the treatment manual is informed
by the core conflictual relationship theme approach [22].
Interpersonal art psychotherapy is delivered in 15 ther-
apy sessions of up to 1 h. Four HCPC registered art psy-
chotherapist (one in each site) have received a 2-day
training in the use of the treatment manual. The typical
structure of therapy sessions includes the therapist giv-
ing an introduction to the session content followed by a
directed art activity and a discussion between the ther-
apist and participant.
Including drawing tasks in sessions helps therapists
and clients to remember what has been said or what the
focus of a session was. Drawings can act as a helpful rec-
ord that can be referred back to during the course of
therapy. In clinical practice it has also been the case that
the act of drawing in therapy sessions has prompted
some people to remember details of an event they are
trying to recall.
Initial therapy sessions focus on helping the patient to
identify immediate problems followed by identifying
their existing positive coping skills and how they are be-
ing used and/or introducing additional coping skills if
needed. The patient is then asked to give accounts of
their relationships and examples of social interactions.
The patient is then asked to think about current or past
events and draw pictures of them to aid discussion with
the therapist. The content that has been elicited and dis-
cussed with the patient in the proceeding sessions is
then used to develop or formulate a shared understand-
ing with the patient about reoccurring themes in their
accounts of interpersonal interactions that are strongly
associated with conflict or aggression. Near the end of
therapy, the patient is asked to look ahead and think
about themselves in the future including their aspira-
tions or specific personal goals. To end the therapy, a
review of the content of all sessions takes place and the
patient leaves with a personalised summary and closing
letter from the therapist.
The session schedule is as follows: 1 to 3—identifying
current problems and coping strategies; 4 to 5—relating to
others; 6 to 10—personal life events; 11 to 12—interper-
sonal themes; 13 to 14—imagining the future; and 15—end
of therapy review. The sessions focus on combined compo-
nents to develop a shared understanding with the client
about their dominant interpersonal styles of interacting
with others. This includes raising awareness of themes re-
lated to the client’s underlying needs or ‘wish’ for particular
responses from the people they are interacting with.
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Attentional condition
Within the single-case design, an attentional condition
will be provided. Participants are asked to complete 15
sessions of up to 1 h of mindful colouring-in. During the
activity, participants will be given additional instructions
by the therapist to breathe slowly and notice what they are
doing ‘in the here and now’. Sessions will be delivered by a
qualified art psychotherapist and will be equivalent in
dose, in terms of number of sessions, to the manualised
interpersonal art psychotherapy treatment. Criteria for
assessing acceptability of the attentional condition in this
study will include the participant’s perception of appropri-
ateness of the intervention for addressing the target prob-
lem and willingness to adhere to treatment [23].
Outcomes
Feasibility outcomes
Objective 1, willingness to be randomised and clinician’s
willingness to recruit, will be evaluated by assessing the
number of eligible patients who were recruited at each
site and the number of patients who declined (Add-
itional file 1). For objective 2, issues related to seeking
informed consent and potential for coercion will be re-
ported by locally based members of the research team.
The same reporting process will be utilised for objective
3 with research assistants reporting feedback from pa-
tients at each data collection point on the burden of out-
come questionnaires. The level of completion of
questionnaires (instrument and item response rates) will
be monitored within routine data integrity checks. Ob-
jective 4, describing routine care, will be carried out
from reviewing individual patient treatment plans. Ob-
jective 5, monitoring attrition and acceptability, will be
addressed by a combination of recording attendance to
treatment and from post-therapy client interview report-
ing and retention for follow-up data collection. Objective
6, assessing contamination, will be met by crosschecking
information collected for objective 5 and by using the
treatment fidelity checklist being used to assess objective
7, therapist adherence to the manual, on a sample of
audio recordings from the attentional control condition.
Primary outcome
Outcome measures will be used to carry out objective 3.
The Modified Overt Aggression Scale (MOAS) [19]
measures both the frequency (< 10 or > 10 observations)
in the previous 7 days and the severity of aggression. It
measures four types of aggression: (a) verbal aggression,
(b) physical aggression against objects, (c) physical ag-
gression against self, and (d) physical aggression against
other people. Agreement between raters for MOAS total
scores is (intra-class correlation coefficient (ICC)) of
0.93, verbal aggression (ICC = 0.90), and physical aggres-
sion against others (ICC = 0.90) [24].
Secondary outcomes
A battery of validated psychological and quality of life
measures will be administered at pre-therapy, post-
therapy, and follow-up including the Brief Symptom
Inventory (BSI) [25], Novaco Anger Scale (NAS) [26],
ICEpop CAPability Quality of Life measure for Adults
(ICECAP-A V2) [27], and Glasgow Anxiety Scale for
people with Intellectual Disability (GAS-ID) [28].
Frequency of routine clinical risk incidents such as
periods of seclusion, use of rapid tranquilising medica-
tion, and use of prevention and management of violence
and aggression techniques will be logged.
A semi-structured client interview will be conducted
with participants following the end of treatment. Ques-
tions are designed to elicit responses from the partici-
pant about helpful and unhelpful aspects of therapy and
the suitability and acceptability of treatment with add-
itional questions about participant’s experience of taking
part in the study. Thematic analysis [29] will be carried
out on all interview transcripts.
Participants included in the single-case design compo-
nent of the study will complete an additional continuous
measure in the form of a daily anger rating scale. This is
a visual self-report ‘thermometer style’ anger scale which
has been adapted and simplified as recommended by
our PPI (Patient and Public Involvement).
Study settings
Participants will be recruited from four NHS secure
hospital sites in England including three medium/low
secure hospitals and one high secure hospital.
Inclusion criteria for patients
 An inpatient in a NHS secure hospital having been
assessed with IQ of between 55 and 79 (within a
range including moderate/mild/borderline intellectual
disability). Age 18 to 60 years (within the age range
for patients treated in the service) and able to give
informed consent. Having a historic and continuing
presentation of emotional control difficulties and/or
observed aggression or antagonistic behaviour that
puts the individual at odds with other people (as
identified by the clinical team).
 The patient’s involvement in the study is supported
by their responsible clinician and/or multidisciplinary
care team.
Patient exclusion criteria
 Unable to give informed consent. Having no clinical
indicators for psychotherapeutic treatment. Planned
discharge from hospital within 12 months of the
start of the study.
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 Receiving active assessment or treatment, including
medication dose titration, for acute psychotic
symptoms.
Randomisation and allocation
Blinding to treatment is not possible in this study. The
random allocation sequence was generated using a
computer-based statistical software package. During the
study, the random allocation sequence will be held by a
research assistant who is wholly independent from the
recruitment process. Allocation concealment will be in
place beyond the first assessment point following which
local therapists can request the allocation via email con-
tact with a research assistant on a participant by partici-
pant basis. Participants can then be informed if they
have been assigned to either interpersonal art psycho-
therapy or to the waiting list and re-assessed at 4 months
by a research assistant.
Ethics and consent
Independent ethical approval has been granted by a local
research ethics committee and the NHS Health Research
Authority. The patients taking part in this study will
have learning disabilities and be receiving inpatient care.
Capacity to consent will be checked in the following
ways: the Mental Capacity Act of 2005 will be followed
and the patient’s responsible clinician will be advised
that capacity to consent to take part in research is in the
study inclusion criteria. Should there be any concern
raised by the patient, their responsible clinician/care
team or a member of the research team regarding cap-
acity to consent an ‘empirical assessment of capacity to
consent’ [30] will be carried out by a member of the
research team. No further action will be taken if the pa-
tient is assessed to lack capacity. Patients will be initially
approached by their responsible clinician or a member
of their immediate care team to inform them about the
study. If the patient would like further information about
taking part in the study, this will be provided in written
form via the study information sheet. Should patients re-
quire this information to be read aloud to them, this will
be carried out by care staff who work closely with them
and know them well. Patients will be given a minimum
of 2 days to decide if they would like to take part in the
study after receiving the study information sheet allow-
ing them time to consider the information. Within the
study information and consent form, patients will be in-
formed that they can withdraw from the study at any
time if they change their mind about participation, with-
out penalty. If patients withdraw during the study, they
will be asked if the researchers can include data col-
lected up to that point in the study. Should they wish to
proceed, they will be invited to a one-to-one meeting
with a member of staff or research assistant and the
study information and consent sheet will be reviewed
with them and read aloud should they require this. Pa-
tients will be invited to have a member of staff who
knows them well present at this meeting should they so
wish. The voluntary nature of their involvement in this
study and being able to withdraw from the study at any
point without prejudice to further treatment will be ex-
plicitly stated on the study consent form. Recruitment of
patients involved in current research or having recently
been involved in research is not an exclusion criteria for
participation in this study. We will not be asking poten-
tial participants to declare if they have recently been in-
volved in research during any stage of the study.
Confidentiality
All members of the study team are NHS staff and/or
contracted to follow NHS trust policies and procedures
for confidentiality and information governance in line
with good clinical practice. No identifiable information
about participants will be used in any report or publica-
tion. All personal data from participants will be anon-
ymised using a unique identifier code number.
Sample size
Twenty patients will be randomly assigned across both
treatment allocations. The sample size for this feasibility
study is limited due to a number of factors including
limitations of time and budget, the intensity of the inter-
vention, and the nature of the settings that it is taking
place in. Participants are being recruited from four NHS
hospitals in England with low, medium, and high levels
of security. Smaller numbers of participants in multiple
sites maximises the potential to assess feasibility objec-
tives across a range of complex secure healthcare set-
tings. This multi-site study will assist in future trial
planning and inform feasibility from multi-level perspec-
tives regarding issues and occurrences that could inform
procedures related to recruitment, treatment acceptabil-
ity, therapist adherence, and institutional support.
Single-case design
Four patients (non-randomised) will be recruited for a
single-case design component of the study to assess the
acceptability of an attentional condition.
Data management
Data will be collected at each study site including demo-
graphic data and current treatment; outcome measures
will be collected during baseline, pre-therapy, post-
therapy, and at follow-up assessment. Data management
procedures will comply with NHS policies on information
governance and data protection. Data will be anonymised
using a unique participant identifier code and entered
onto a password-protected NHS computer. Digital audio
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data will be wiped from the recording device after being
transferred to an NHS password-protected computer.
Consent to use an audio digital recording of therapy ses-
sions is included on the consent form. Hard copies of
questionnaires and interview transcripts will be stored in a
locked filing cabinet in secure offices.
Statistical methods
Simple descriptive estimation of parameters, for example
mean and standard deviation (SD), will be carried out
for the outcome measures. Estimation will be carried
out using the population as a whole and by group. The
numeric measures will be summarised using mean, me-
dian, SD, and interquartile range while categorical data
will be expressed in terms of the proportion (or percent)
of participants within each category and available sample
size for each measure will be quoted throughout. Esti-
mates of mean and SD for the measures will be carried
out considering each time point separately. Feasibility
study objectives will be summarised in the manner of
categorical data. Estimates will be used to inform future
study design.
Data monitoring and interim analyses
A data monitoring committee will not be in place. Nega-
tive reactions and experiences of participants in the
study and/or adverse clinical concerns can be raised by
the participant, their responsible clinicians, or members
of their immediate care team. It is an inclusion require-
ment that the participant’s responsible clinician and/or
multidisciplinary care team support their involvement in
the study and are therefore informed about the nature of
the treatment being carried out.
Harm
Interpersonal art psychotherapy and mindful colouring-
in are non-invasive and non-intrusive interventions;
however, individual psychological therapies can raise is-
sues of concern for some patients. The main focus of
the treatment in this study is to support a reduction in
patient’s harmful and anti-social behaviours. To reduce
the potential for participants to experience increased
levels of distress, both in and following therapy sessions,
the treatment will be conducted by qualified art psycho-
therapists in private/confidential rooms in familiar sur-
roundings with trained members of the patient
immediate care team on hand to support them should
this be required.
Auditing
The sponsor can select this study for audit either ‘for
cause’ or as part of regular annual audits. Auditing
would include a review of the trial master file and/or
investigator site file/s.
Protocol amendments
Notification of both substantial and/or non-substantial
protocol amendments will be directed to the responsible
Research Ethics Committee for consideration.
Access to data
Only those in the research team will have access to the
data.
Post-trial care
All patients will continue to receive usual care in the
NHS secure setting they are being treated in. Study in-
formation forms given to participants include informa-
tion about where they can raise concerns or complaints
related to the study. Study information states that if they
have any concerns they can speak to a member of the
research team, a member of their immediate care team,
or their local NHS patient advice and liaison service
(PALS) representative.
Dissemination
The feasibility study results will be communicated via
conference presentations and peer-reviewed publications
and via participating NHS Trust and University websites.
Discussion
This study has been designed to establish feasibility and
inform future design of a RCT to evaluate the effective-
ness of manualised interpersonal art psychotherapy.
Findings will inform the procedures and provide data to
calculate the standard deviation of outcome measures
and degrees of certainty and estimation of numbers of
patients required for a future trial. Additional feasibility
objectives will explore therapist adherence to the man-
ual, study, and treatment acceptability and inform the
design of a novel attentional control condition.
Potential challenges within this study include clini-
cian’s willingness to approach patients for the study
without prior knowledge of the manualised interpersonal
art psychotherapy treatment. Strategies being employed
to support uptake at sites include providing bespoke
information to multidisciplinary teams and, where
needed, specific site visits to give presentations to the
wider clinical teams.
It is clear that there are a small number of evidence-
based psychological treatments for people with learning
disabilities [20] and it is important that feasibility work
is carried out to maximise the potential for successful
completion of RCTs. The study aims and objectives will
support a robust assessment of feasibility and inform
future trial design.
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